Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).

Crowell advised Kanders on all transactional and regulatory aspects of the transaction, including corporate and M&A, government contracts, tax, IP, cybersecurity, labor and employment, life sciences, and more.

The multidisciplinary, cross-office, international team included Stephen J. McBrady, Lex Eley, Christine K. Lane, Justin Lurie, Michael E. Samuels, Ken Itrato, Scott J. Moore, Thomas E. Williams, William J. Bruno, Kate M. Growley, Eric Homsi, Paul Freeman, Charbel M. Maakaron, Simon Evers, Matthew F. Ferraro, Kristy J. Wrigley-Durer, Andrew W. Bagley, Justin B. Weiss, Neil Campbell, Ryan Flynn, David Steenberg, Allison Skager, Nimrah Najeeb, Amanda Kwagala, Sarah Styles, Maria Stracqualursi, Dan Liu, Sarah Rippy, Savannah Gabriel, Corey B. Hirsch-Lestienne, Jason Sandoval, Matthew Morehead, Lillie Drenth, Candice Gwak, Emily McGovern, Ahmad El Lakkis, Thomas Hurtubise, Israel Guerrero, Courtney Estell, and Jennifer Koertge.

 For more information, click here.